[PDF][PDF] Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan …
…, G Porcile, L Fioretto, C Orlandini… - Journal of clinical …, 2007 - researchgate.net
Purpose The Gruppo Oncologico Nord Ovest (GONO) conducted a phase III study comparing
fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI [irinotecan 165 mg/m2 day …
fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI [irinotecan 165 mg/m2 day …
Survival of metastatic breast carcinoma patients over a 20‐year period: A retrospective analysis based on individual patient data from six consecutive studies
A Gennari, PF Conte, R Rosso, C Orlandini, P Bruzzi - Cancer, 2005 - Wiley Online Library
BACKGROUND The expectation of improvement in patient survival with administration of new
chemotherapy agents for metastatic breast carcinoma (MBC) is not consistently supported …
chemotherapy agents for metastatic breast carcinoma (MBC) is not consistently supported …
Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine
…, V Mey, N Funel, S Nannizzi, S Ricci, C Orlandini… - Cancer research, 2006 - AACR
Gene expression analysis may help the management of cancer patients, allowing the
selection of subjects responding to treatment. The aim of this study was the characterization of …
selection of subjects responding to treatment. The aim of this study was the characterization of …
The detection of androgen receptor splice variant 7 in plasma-derived exosomal RNA strongly predicts resistance to hormonal therapy in metastatic prostate cancer …
…, E Biasco, S Crucitta, L Derosa, E Rofi, C Orlandini… - European urology, 2017 - Elsevier
Background The androgen receptor splice variant 7 (AR-V7) is associated with resistance to
hormonal therapy in castration-resistant prostate cancer (CRPC). Due to limitations of the …
hormonal therapy in castration-resistant prostate cancer (CRPC). Due to limitations of the …
Correlation of CDA, ERCC1, and XPD Polymorphisms with Response and Survival in Gemcitabine/Cisplatin–Treated Advanced Non–Small Cell Lung Cancer …
…, R Di Marsico, A Antonuzzo, C Orlandini… - Clinical cancer …, 2008 - AACR
Purpose: Selecting patients according to key genetic characteristics may help to tailor
chemotherapy and optimize the treatment in non–small cell lung cancer (NSCLC). Polymorphisms …
chemotherapy and optimize the treatment in non–small cell lung cancer (NSCLC). Polymorphisms …
No benefit of adjuvant Fluorouracil Leucovorin chemotherapy after neoadjuvant chemoradiotherapy in locally advanced cancer of the rectum (LARC): Long term …
…, FM Osti, B Manfredi, M Coppola, C Orlandini… - Radiotherapy and …, 2014 - Elsevier
Background and purpose To evaluate the effect of adjuvant chemotherapy (ACT) in locally
advanced rectal cancer (LARC) after neoadjuvant chemoradiation (NACT-RT). The study was …
advanced rectal cancer (LARC) after neoadjuvant chemoradiation (NACT-RT). The study was …
Randomized controlled trial of harmonic scalpel use during thyroidectomy
…, GL Dionigi, J D'Agostino, C Orlandini… - … –Head & Neck …, 2006 - jamanetwork.com
Objective To compare operative factors, postoperative outcomes, and surgical complications
of thyroidectomy when using the harmonic scalpel (HS) vs conventional hemostasis (CH). …
of thyroidectomy when using the harmonic scalpel (HS) vs conventional hemostasis (CH). …
AIDS related neoplasms in Genoa, Italy
…, MA Orengo, C Casella, E Garrone, C Orlandini… - European journal of …, 1995 - Springer
The study defines the epidemiological characteristics of HIV-infection in the population of
Genoa and estimates the entity of AIDS-cancer association. The cohort includes 317 subjects …
Genoa and estimates the entity of AIDS-cancer association. The cohort includes 317 subjects …
Women with endometriosis at first pregnancy have an increased risk of adverse obstetric outcome
…, G Cevenini, S Vannuccini, C Orlandini… - The Journal of …, 2015 - Taylor & Francis
Objective: To evaluate pregnancy, delivery and neonatal outcome in singleton primiparous
versus multiparous women with/without endometriosis. Methods: Multicentric, observational …
versus multiparous women with/without endometriosis. Methods: Multicentric, observational …
Phase II trial of sorafenib in combination with 5-fluorouracil infusion in advanced hepatocellular carcinoma
…, M Ricasoli, M Iannopollo, C Orlandini… - Cancer chemotherapy …, 2012 - Springer
Purpose Sorafenib improves overall survival and time to progression of advanced hepatocellular
(aHCC) patients such as demonstrated in 2 phase III trials. However, aHCC patients’ …
(aHCC) patients such as demonstrated in 2 phase III trials. However, aHCC patients’ …